The Pharmacy Times® Allergy resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
What can we help you find?
Inhaler misuse may result in more asthma attacks.
Future studies will help us determine who will most benefit from egg oral immunotherapy.
The needed-free treatment option, ARS-1, is designed to be easy-to-use, convenient and more reliable than other emergency epinephrine treatments for severe allergic reactions.
Teva’s Epinephrine Injection May Not Undercut Mylan’s on Price, but It Could Help in Addressing Shortages
Nasal congestion can negatively affect quality of life by interfering with day-to-day activities and disrupting sleep patterns.
A pair of pivotal Phase 3 placebo-controlled trials that evaluated dupilumab (Dupixent, Sanofi and Regeneron) for adults with inadequately-controlled chronic rhinosinusitis with nasal polyps met all primary and secondary endpoints.
National Penicillin Allergy Day highlights negative impact of Inaccurate allergy diagnoses.
One lot of Montelukast Sodium Tablets is being voluntarily recalled by Camber Pharmaceuticals, due to a safety risk for consumers.
The FDA has approved the first generic epinephrine auto-injector for the emergency treatment of allergic reactions, including anaphylaxis.
Allergic rhinitis, also known as hay fever, is a common condition that causes symptoms such as congestion, nasopharyngeal itching, rhinorrhea, and sneezing.
Between 10% and 20% of students in kindergarten through high school have chronic illness.
Early life exposure to pet or pest allergens may reduce the likelihood of asthma development in young children, according to a recently-published study in the Journal of Allergy and Clinical Immunology.1